H.R. 5526
119th Congress
Biosimilar Red Tape Elimination Act
10
Cosponsors
3
Actions
0
Amendments
1
Committees
—
Since introduced
Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action
Referred to the House Committee on Energy and Commerce.
19 September 2025·10 months ago
Timeline
3 actions
Referred to the House Committee on Energy and Commerce.
19 September 2025 · IntroReferral
Introduced in House
19 September 2025 · IntroReferral
Introduced in House
19 September 2025 · IntroReferral
Sponsorship
10 cosponsors
Sponsor
Republican:Rep. Pfluger, August [R-TX-11]TXCosponsors
- Democrat440%
- Republican660%
- Republican:Rep. Wittman, Robert J. [R-VA-1]VA
- Republican:Rep. Goldman, Craig A. [R-TX-12]TX
- Democrat:Rep. Sorensen, Eric [D-IL-17]IL
- Republican:Rep. Moore, Blake D. [R-UT-1]UT
- Republican:Rep. Fine, Randy [R-FL-6]FL
- Republican:Rep. Owens, Burgess [R-UT-4]UT
- Democrat:Rep. Vasquez, Gabe [D-NM-2]NM
- Republican:Rep. Crenshaw, Dan [R-TX-2]TX
- Democrat:Rep. Auchincloss, Jake [D-MA-4]MA
- Democrat:Rep. Landsman, Greg [D-OH-1]OH
Classification
Policy area
HealthLegislative subjects
Drug safety, medical device, and laboratory regulationGovernment information and archivesLicensing and registrationsPrescription drugs
Committees
1
Energy and Commerce Committee
House · Standing
- Referred To19 Sept 2025
Cosponsor momentum
Cumulative over time
Cosponsors grew from 1 on 19 September 2025 to 10 on 21 July 2026.
Track Biosimilar Red Tape Elimination Act as it moves through Congress
Get alerts on votes, amendments, and stock-market impact